← Back to Intel
Insider ActivityNGNE
McMinn Rachel, Chief Executive Officer, Director at Neurogene Inc., sold $74K of NGNE
Updated Jun 14, 2026
McMinn Rachel
Chief Executive Officer, Director
Neurogene Inc. ·
$NGNE
Transaction Details
| Insider | McMinn Rachel |
|---|---|
| Title | Chief Executive Officer, Director |
| Company | Neurogene Inc. |
| Ticker | NGNE |
| Transaction Type | Sale |
| Transaction Date | 2026-03-26 |
| Shares Traded | 3,352 |
| Price Per Share | $22.0749 |
| Total Value | $74K |
| Filed Date | 2026-03-30 |
| Accession Number | 0001606302-26-000005 |
Ownership Context
| Shares Owned After Transaction | 1,344,307 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001606302-26-000005
Other Insider Trades — NGNE
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Cvijic Christine Mikail | President and CFO, Director | sold | $144K | 2026-05-06 |
| Shafer Christina | Chief Commercial Officer | traded | — | 2026-05-05 |
| Cvijic Christine Mikail | President and CFO | sold | $55K | 2026-03-26 |
| Jordan Julie | Chief Medical Officer | sold | $18K | 2026-03-26 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for NGNE — Neurogene Inc. →
Track NGNE insider activity in real time on The Wire →
Get alerts when McMinn Rachel files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 14, 2026 at 07:21 UTC